Concepedia

C. K. CHU

CK

Statistics

Publications

32

Citations

2.3K

H-Index

22

Active since

1976

Affiliations

University of Georgia(Current)

Cornell University

Yale University

Memorial Sloan Kettering Cancer Center

Kettering University

C. K. CHU is an author at University of Georgia specializing in pharmacology, nucleoside analogs, and antiviral pharmacology.

Publications per year

1976–2013

32

Publications

32

Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides

Raymond F. Schinazi, Robert M. Lloyd, M. Hong Nguyen et al. · Antimicrobial Agents and Chemotherapy · 1993 · 367 citations

, , +14

Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes

Raymond F. Schinazi, C. K. CHU, A Peck et al. · Antimicrobial Agents and Chemotherapy · 1992 · 265 citations · Full text

, , +9

Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus

C. K. CHU, Tianwei Ma, Kirupa Shanmuganathan et al. · Antimicrobial Agents and Chemotherapy · 1995 · 229 citations

, , +14

Deoxycytidine deaminase-resistant stereoisomer is the active form of (+/-)-2',3'-dideoxy-3'-thiacytidine in the inhibition of hepatitis B virus replication.

C.N. Chang, Shin-Lian Doong, Junhu Zhou et al. · Journal of Biological Chemistry · 1992 · 225 citations · Full text

, , +13

Inhibition of hepatitis B virus by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyl uracil

S. Balakrishna Pai, S H Liu, Y.‐L. Zhu et al. · Antimicrobial Agents and Chemotherapy · 1996 · 141 citations · Full text

, , +12

1–5 of 32